RESPIRATION

Scope & Guideline

Connecting Scholars to Transform Respiratory Care

Introduction

Delve into the academic richness of RESPIRATION with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0025-7931
PublisherKARGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 1944 to 2024
AbbreviationRESPIRATION / Respiration
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'RESPIRATION' focuses on advancing knowledge and practice in respiratory medicine through a comprehensive exploration of various themes related to lung health, diseases, and therapies. It aims to publish high-quality research that addresses both clinical and translational aspects of pulmonary medicine.
  1. Clinical Management of Respiratory Diseases:
    This area encompasses studies on the diagnosis, treatment, and management strategies for various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease.
  2. Innovative Therapeutic Approaches:
    Research in this scope includes the development and evaluation of new therapies, such as biologics, endobronchial valves, and minimally invasive procedures like cryobiopsy and robotic-assisted bronchoscopy.
  3. Pulmonary Rehabilitation and Patient Quality of Life:
    This focus area examines the impact of rehabilitation programs and interventions on improving quality of life and functional outcomes for patients with chronic respiratory illnesses.
  4. Epidemiological and Public Health Studies:
    Studies aimed at understanding the prevalence, risk factors, and public health implications of respiratory diseases, including those related to COVID-19, tuberculosis, and environmental influences.
  5. Technological Advances in Diagnostics:
    This includes research on the use of advanced imaging techniques, such as CT and ultrasound, and novel diagnostic tools for accurate assessment of pulmonary conditions.
  6. Translational Research in Pulmonology:
    This scope emphasizes the integration of laboratory findings into clinical practice, including studies on biomarkers, genetic factors, and the molecular mechanisms underlying respiratory diseases.
Recent publications in 'RESPIRATION' reveal emerging trends and themes that reflect the evolving landscape of respiratory research. These areas are gaining traction as researchers seek to address pressing clinical challenges in pulmonology.
  1. Impact of COVID-19 on Respiratory Health:
    A significant increase in research focused on the long-term effects of COVID-19, including pulmonary sequelae and rehabilitation strategies for recovering patients, highlighting the pandemic's lasting impact on respiratory health.
  2. Personalized Medicine and Targeted Therapies:
    An emerging focus on personalized approaches in treatment, including the use of biomarkers for predicting responses to therapies, particularly in chronic conditions like asthma and COPD.
  3. Telemedicine and Remote Monitoring:
    The rise of telemedicine in the management of respiratory diseases, driven by the COVID-19 pandemic, is becoming a prominent theme, emphasizing the need for innovative solutions for patient care.
  4. Integration of Multidisciplinary Approaches:
    Research increasingly emphasizes collaborative approaches involving pulmonologists, radiologists, and other specialists to enhance diagnostic accuracy and treatment outcomes in complex respiratory conditions.
  5. Environmental and Lifestyle Factors in Respiratory Diseases:
    Growing interest in the impact of environmental factors, such as air quality and lifestyle habits, on respiratory health, reflecting a broader understanding of disease etiology.

Declining or Waning

While the journal maintains a robust focus on various aspects of respiratory medicine, certain themes have seen a decline in prominence over recent years, indicating a shift in research priorities and interests within the field.
  1. Traditional Surgical Approaches in Pulmonary Medicine:
    There is a noticeable decrease in studies focusing on conventional surgical interventions for lung diseases, as more attention shifts towards minimally invasive techniques and non-surgical treatment options.
  2. Longitudinal Cohort Studies without Novel Insights:
    Research involving long-term follow-ups without significant novel findings or advancements in understanding disease mechanisms appears to be less prioritized, as the field moves towards more innovative and impactful studies.
  3. Basic Research in Animal Models:
    There has been a reduction in papers focusing solely on animal model studies without direct translational relevance to human respiratory diseases, reflecting a growing preference for research that can be quickly applied in clinical settings.

Similar Journals

Jornal Brasileiro de Pneumologia

Connecting researchers for a healthier tomorrow in respiratory care.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Zeitschrift fur Pneumologie

Empowering Knowledge for Better Respiratory Care
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Journal of Thoracic Disease

Advancing respiratory health through innovative research.
Publisher: AME PUBLISHING COMPANYISSN: 2072-1439Frequency: 12 issues/year

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Pioneering research in respiratory health and intensive care.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

BMJ Open Respiratory Research

Advancing respiratory health through innovative research.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.

REVUE DES MALADIES RESPIRATOIRES

Enhancing understanding of respiratory diseases since 1984.
Publisher: MASSON EDITEURISSN: 0761-8425Frequency: 10 issues/year

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.

EUROPEAN RESPIRATORY JOURNAL

Fostering Excellence in Respiratory Research
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Tuberculosis and Respiratory Diseases

Uncovering breakthroughs in tuberculosis research.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Chronic Respiratory Disease

Exploring breakthroughs in respiratory health.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-9723Frequency: 1 issue/year

Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.

Respiratory Investigation

Connecting scholars to revolutionize respiratory medicine.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.